AUREON LABORATORIES SECURES $20 MILLION IN SERIES B VENTURE CAPITAL FUNDING

Aureon Laboratories (formerly Aureon Biosciences) announced today that it has closed on a Series B round of venture capital financing, which secured $20 million for the Company. The group of investors participating in the financing included Atlas Venture, Sprout Group, Pfizer, and a consortium of European investors with expertise in the medical diagnostics industry. Aureon Laboratories specializes in the creation of next-generation tissue analysis by integrating clinical, micro-anatomic and molecular profiles of disease.

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=20786220&full=1)